Mental Health Practice Owners: What the Latest M&A Trends Reveal About Your Options (2020–2025)
- Feb 14, 2025
- 4 min read
Updated: Feb 23
The mental health M&A market has undergone a full cycle over the past six years — from rapid expansion, to slowdown, and now recovery. But the most important story for practice owners is not just how many deals happened. It’s who is buying, when they are buying, and which types of practices are in the highest demand.
The latest data from Mergium Advisor’s research shows that while buyers remain highly interested in mental health practices, their priorities — and the opportunities for owners — are evolving.
Deal Volume Recovered in 2025 — But Buyers Are More Selective
One of the clearest signals from Mergium Advisor’s data is the strong rebound in early 2025.
Transaction volume reached 36 deals in Q1 2025, making it one of the most active quarters in recent years.
However, activity slowed during the rest of the year:
23 deals in Q2
18 deals in Q3
11 deals in Q4
This pattern suggests that while buyer demand remains strong, acquisitions are happening more selectively.
For practice owners, this reflects an important shift:
Buyers are still acquiring — but they are prioritizing the right practices, rather than acquiring aggressively across the board.
This makes preparation, profitability, and operational stability more important than ever.
Strategic Buyers Are Playing a Larger Role
Another key trend is the growing influence of strategic buyers.
Throughout multiple quarters in 2024 and 2025, strategic buyers accounted for a large portion of transactions, often representing 40% or more of deals.
Strategic buyers typically include:
Larger mental health platforms
Healthcare organizations
Established behavioral health companies
This matters because strategic buyers often acquire practices to expand geographically or strengthen clinical offerings.
This creates additional opportunities for owners, as there are now multiple types of buyers actively pursuing acquisitions.
Private equity remains active — particularly through platform acquisitions — but the balance between private equity and strategic buyers has become more even.
Psychiatry and Therapy Practices Continue to Attract Strong Buyer Interest
Mergium Advisor’s research also shows where buyers are focusing within mental health.
Two categories dominate acquisition activity:
Talk therapy
Psychiatry
Talk therapy represents the largest share of transactions overall.
However, psychiatry’s share increased significantly between 2020 and 2024, before remaining at elevated levels in 2025.
At the same time, other segments such as residential treatment and hospitalization represent a smaller portion of overall deal activity.
This reflects a clear focus on outpatient mental health practices.
For owners of outpatient psychiatry and therapy practices, this is particularly important:
Outpatient practices continue to be the primary target of acquisition activity.
What This Means for Practice Owners
Based on Mergium Advisor’s data, several key conclusions emerge:
1. Buyers Are Still Active
The rebound in 2025 shows that mental health remains a priority for acquirers.
2. Strategic Buyers Are Providing Additional Exit Opportunities
More buyers are participating in the market, expanding options for owners.
3. Outpatient Psychiatry and Therapy Practices Remain in Strong Demand
These specialties represent the majority of transactions.
4. Buyers Are Becoming More Selective
The moderation in deal activity after Q1 2025 suggests buyers are focusing on practices that are well-positioned operationally.
Final Thoughts: The Window Remains Open — But Preparation Matters
The mental health M&A market today is active, but more disciplined than during its peak years.
Demand remains strong — particularly for outpatient psychiatry and therapy practices.
However, buyers are taking a more measured approach, and practices that are operationally strong are likely to attract the greatest interest.
For practice owners considering their future, this environment offers meaningful opportunities — especially for those who understand how the market is evolving.
(*) Notes:
This analysis:
Includes companies that offer outpatient services, in person or via telehealth, B2C and/or B2B, offering psychiatry, medication management, talk therapy, TMS, ketamine and esketamine therapies and other psychedelic treatments. It also includes mental health hospitals, and residential, IOP, and PHP treatments.
Types of transactions and buyers:
PE (Buyout): Transactions by private equity firms (“PE”).
PE (Secondary Buyouts (SBOs)): Sale of companies by one PE to another PE.
PE (Platform): Typically, after closing of an M&A by a private equity, the acquired company (“Platform”) grows through acquisitions (“add-ons”) of smaller firms and de novo locations. The acquisitions of those smaller companies are registered here.
Strategic Buyer: These are acquisitions made by a company that is not a PE, nor a Platform of a PE.
The study only includes what is widely understood as mergers and acquisitions and does not include private placements, i.e., acquisitions of shares and debt instruments by private investors when a company sells newly issued shares or debt. These transactions are regulated by the U.S. Securities and Exchange Commission and usually executed applying a federal exemption, like rule 506 (b).
Additional resources:
If you need assistance selling or valuing your mental health company, contact us.
If you need to read more about selling a business, read more
If interested in reading more articles and insights by Mergium, click here
If interested in knowing about our experience in selling / acquiring healthcare services companies, click here